Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT04435197 · COMPLETED
Trial details
- NCT number
- NCT04435197
- Sponsor
- Ruijin Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-11
- Primary completion
- 2024-06-30
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.